Kevin Woolard
Overview
Explore the profile of Kevin Woolard including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
1123
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Finno C, Rogers S, Donnelly C, Affolter V, Woolard K, Miller A, et al.
Vet Pathol
. 2025 Feb;
:3009858241312623.
PMID: 39916473
Equine spinal neurodegenerative conditions are frequently encountered in sport and racing horses and may be career-ending diagnoses. To further define the spatial transcriptomic landscape of equine dorsal root ganglia (DRG)...
2.
Pandit P, Smith W, Finno C, Aleman M, Conrad P, Packham A, et al.
Vet Parasitol
. 2024 Jun;
330:110219.
PMID: 38897057
Equine protozoal myeloencephalitis (EPM) is a challenging disease to diagnose in horses with neurological signs. To optimize contemporary diagnostic testing, including the use of serum:CSF antibody ratios, the SarcoFluor antibody...
3.
Zakimi N, Mazcko C, Toedebusch C, Tawa G, Woolard K, LeBlanc A, et al.
Acta Neuropathol
. 2024 Feb;
147(1):43.
PMID: 38376604
No abstract available.
4.
Ma Y, Peng S, Donnelly C, Ghosh S, Miller A, Woolard K, et al.
J Vet Intern Med
. 2023 Nov;
38(1):417-423.
PMID: 37937700
Background: Equine neuroaxonal dystrophy/equine degenerative myeloencephalopathy (eNAD/EDM) is an inherited neurodegenerative disorder associated with vitamin E deficiency. In humans, polymorphisms in genes involved in vitamin E uptake and distribution determines...
5.
Rebhun R, York D, Cruz S, Judge S, Razmara A, Farley L, et al.
J Immunother Cancer
. 2022 Jun;
10(6).
PMID: 35680383
Purpose: Although recombinant human interleukin-15 (rhIL-15) has generated much excitement as an immunotherapeutic agent for cancer, activity in human clinical trials has been modest to date, in part due to...
6.
Hales E, Habib H, Favro G, Katzman S, Sakai R, Marquardt S, et al.
J Vet Intern Med
. 2021 Jul;
35(5):2473-2485.
PMID: 34331715
Background: Equine neuroaxonal dystrophy/equine degenerative myeloencephalopathy (eNAD/EDM) is an inherited neurodegenerative disorder associated with a vitamin E deficiency within the first year of life. Vitamin E consists of 8 isoforms...
7.
Toedebusch R, Grodzki A, Dickinson P, Woolard K, Vinson N, Sturges B, et al.
Neurooncol Adv
. 2021 Jun;
3(1):vdab062.
PMID: 34131649
Background: Glioma-associated microglia/macrophages (GAMs) markedly influence glioma progression. Under the influence of transforming growth factor beta (TGFB), GAMs are polarized toward a tumor-supportive phenotype. However, neither therapeutic targeting of GAM...
8.
Datta S, Sears T, Cortopassi G, Woolard K, Angelastro J
Biomed Pharmacother
. 2020 Dec;
133:111058.
PMID: 33378970
Glioblastoma Multiforme (GBM) tumors contain a small population of glioma stem-like cells (GSCs) among the various differentiated GBM cells (d-GCs). GSCs drive tumor recurrence, and resistance to Temozolomide (TMZ), the...
9.
Sandoval J, Tomilov A, Datta S, Allen S, ODonnell R, Sears T, et al.
Pharmaceuticals (Basel)
. 2020 Dec;
13(12).
PMID: 33255358
Glioblastoma (GBM) is an aggressive tumor of the brain, with an average post-diagnosis survival of 15 months. GBM stem cells (GBMSC) resist the standard-of-care therapy, temozolomide, and are considered a...
10.
Aleman M, Berryhill E, Woolard K, Easton-Jones C, Kozikowski-Nicholas T, Dyson S, et al.
J Vet Intern Med
. 2020 Aug;
34(5):2122-2131.
PMID: 32820825
Background: Sidewinder gait in horses is poorly understood and characterized by walking with the trunk and pelvic limbs drifting to 1 side. Hypothesis/objectives: To report causes, clinical and diagnostic features....